drugset / Trial / NCT00829127
AZD8075 Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers
RandomizedParallel-groupTriple-blindBasic science
Summary
The aims of the study are to evaluate the safety, tolerability and pharmacokinetics of AZD8075 in healthy male subjects at increasing doses when given for 14 days
Timeline
- Start
- 2009-01
- Primary completion
- 2009-01
- Completion
- 2009-01
Outcome
Outcome not reported
Stopped: “Due to termination of study D3801C00001, due to reports of turbid urine.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8075 | Small molecule | 35 mg | Oral |
Indications
No indication recorded.